APA (7th ed.) Citation

Szabados, B., Rodriguez-Vida, A., Duran, I., Crabb, S., van der Heijden, M., Pous, A. F., . . . Powles, T. (2020). 199O A phase II study investigating neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive bladder cancer: Final analysis. Annals of Oncology, 31, S1319. https://doi.org/10.1016/j.annonc.2020.10.211

Chicago Style (17th ed.) Citation

Szabados, B.E, et al. "199O A Phase II Study Investigating Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Bladder Cancer: Final Analysis." Annals of Oncology 31 (2020): S1319. https://doi.org/10.1016/j.annonc.2020.10.211.

MLA (9th ed.) Citation

Szabados, B.E, et al. "199O A Phase II Study Investigating Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Bladder Cancer: Final Analysis." Annals of Oncology, vol. 31, 2020, p. S1319, https://doi.org/10.1016/j.annonc.2020.10.211.